Trial Profile
A Randomized, Blinded-assessor, Single Center Study to Determine if Administration of Sugammadex, When Used to Reverse Deep Neuromuscular Blockade (NMB) After Open Abdominal Surgery, Impacts Hospital Efficiency
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 10 Apr 2019 Status changed from recruiting to completed.
- 07 Nov 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.
- 07 Nov 2017 Planned primary completion date changed from 1 May 2017 to 1 Feb 2018.